The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
1,964 reports and counting
AstraZeneca Raises $200B in Public
AstraZeneca, a Pharmaceuticals company based in 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom, has raised $200B in Public at a $220B valuation led by Public.
AstraZeneca raises $200B Public at $220B valuation
AstraZeneca raises $200B in Public at $220B valuation. Pharmaceutical company...
CatalystShift Software raises $1.1B Late Stage at $1.9B valuation
CatalystShift Software secures $1.1B in Late Stage funding led by General Catalyst, reaching $1.9B valuation as it accelerates growth in the gaming sector.
AccelerateDisrupt Platform raises $1.2B Late Stage at $1.8B valuation
AccelerateDisrupt Platform secures $1.2B in Late Stage funding led by Accel, reaching $1.8B valuation as it accelerates growth in the ai/ml sector.
MomentumGrid Networks raises $1.0B Late Stage at $1.8B valuation
MomentumGrid Networks secures $1.0B in Late Stage funding led by Kleiner Perkins, reaching $1.8B valuation as it accelerates growth in the consumer apps sector.
CatalystSpark Platform raises $1.1B Late Stage at $1.8B valuation
CatalystSpark Platform secures $1.1B in Late Stage funding led by GV (Google Ventures), reaching $1.8B valuation as it accelerates growth in the supply chain sector.
AstraZeneca Headquarters - Office Location & Address
Discover AstraZeneca's headquarters at 1 Francis Crick Ave, Cambridge CB2 0AA. Biopharmaceutical company developing medicines. Learn about the office facilities and work environment.
Wargaming Raises $1.5B in Private
Wargaming, a Gaming company based in 105 Agion Omologiton Avenue, Nicosia, Cyprus, has raised $1.5B in Private at a $2.5B valuation led by Private.
DDB Worldwide Raises $1.5B in Private
DDB Worldwide, a Advertising company based in 437 Madison Avenue, New York, NY 10022, has raised $1.5B in Private at a $3B valuation led by Private.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.